Mergers & Acquisitions - Sorrento Therapeutics


Current filters:

Sorrento Therapeutics

Popular Filters

Sorrento to acquire Concortis Biosystems, gaining ADC technology

Sorrento to acquire Concortis Biosystems, gaining ADC technology


In a second acquisition within a month, USA-based Sorrento Therapeutics says it has entered a definitive…

BiotechnologyConcortis BiosystemsMergers & AcquisitionsSorrento Therapeutics

Sorrento Therapeutics gets clinical-stage chronic pain drug, along with Sherrington acquisition


Sorrento Therapeutics has acquired Sherrington Pharmaceuticals. Financial terms of the deal were not…

CynviloqMergers & AcquisitionsNeurologicalPharmaceuticalresiniferatoxinSherrington PharmaceuticalsSorrento Therapeutics

Sorrento Therapeutics signs exclusive option to acquire IGDRASOL


USA-based Sorrento Therapeutics, Inc. (SRNE: OB) has signed an exclusive option to acquire IGDRASOL,…

IGDRASOLMergers & AcquisitionsOncologyPharmaceuticalResearchSorrento Therapeutics

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top